Advertisement
Screener

ORASURE TECHNOLOGIES, INC (OSUR) Overview

ORASURE TECHNOLOGIES, INC (OSUR) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.09; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.32; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.19; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.26; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.00$2.38$2.82$3.35$3.98$4.722025-11-062026-11-06$2.00$2.80$3.91$5.47$7.65$10.692021-11-082026-11-06$2.00$3.29$5.41$8.88$14.58$23.952016-11-072026-11-06$2.00$3.29$5.41$8.88$14.58$23.952006-11-062026-11-06$1.70$3.04$5.45$9.75$17.44$31.221986-11-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$3.45
Previous close
$3.82
Change
-$0.37
Change (%)
-9.69%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

OSUR
+58.08%
S&P 500
(m)

1 year

OSUR
+20.28%
S&P 500
(m)

3 years

OSUR
-35.58%
S&P 500
(m)

5 years

OSUR
-66.03%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.09

-0.40-0.23-0.070.100.2731 Mar 2025: estimate (m); actual -0.2131 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1930 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.3231 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.0930 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.09(m)(m)
1 Jan 202631 Mar 2026(m)-0.32(m)(m)
1 Jul 202530 Sept 2025(m)-0.19(m)(m)
1 Apr 202530 Jun 2025(m)-0.26(m)(m)
1 Jan 202531 Mar 2025(m)-0.21(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.94

-1.02-0.54-0.060.420.9031 Dec 2021: estimate (m); actual -0.3231 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.2431 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.7231 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.2631 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.9431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.94(m)(m)
1 Jan 202431 Dec 2024(m)-0.26(m)(m)
1 Jan 202331 Dec 2023(m)0.72(m)(m)
1 Jan 202231 Dec 2022(m)-0.24(m)(m)
1 Jan 202131 Dec 2021(m)-0.32(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 30.64M ■ Earnings 6.25M — Profit margin 20.40%

-28.74M-81.1%-6.83M-47.0%15.09M-12.8%37.00M21.4%30 Sept 2025: revenue 27.09M; earnings -13.71M; profit margin -50.63%30 Sept 202531 Dec 2025: revenue 26.76M*; earnings -19.29M*; profit margin -72.06%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 27.93M; earnings -22.38M; profit margin -80.13%31 Mar 202630 Jun 2026: revenue 30.64M; earnings 6.25M; profit margin 20.40%30 Jun 2026

31 Dec 2025 ■ Revenue 115.02M ■ Earnings -68.73M — Profit margin -59.76%

-125.64M-60.8%70.37M-35.8%266.37M-10.8%462.38M14.2%31 Dec 2022: revenue 387.48M; earnings -17.13M; profit margin -4.42%31 Dec 202231 Dec 2023: revenue 405.47M; earnings 53.66M; profit margin 13.23%31 Dec 202331 Dec 2024: revenue 185.83M; earnings -19.50M; profit margin -10.49%31 Dec 202431 Dec 2025: revenue 115.02M; earnings -68.73M; profit margin -59.76%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$3.45(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$3.45High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning OSUR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-49.13M
Profit margin
-43.70%
Return on assets · 12 month
-12.20%
Index membership
(m)
Employees
500.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
601.81K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-4.26%*
Total return · month
6.11%*
Total return · quarter
-15.03%*
Total return · half year
27.35%*
Total return · year to date
58.08%*
Total return · 1 year
20.28%*
Total return · 3 years
-35.58%*
Total return · 5 years
-66.03%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$112.41M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ORASURE TECHNOLOGIES, INC Overview

View more →

(m)

(m)

SEC CIK
1116463
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
220 E FIRST ST, BETHLEHEM, Pennsylvania, 18015, United States
Fiscal year end
1231
Phone
5036416115

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25